Evidence map›Paper›PMID 35759232›Full record

ArticleImmunity, inflammation and disease2022

Weeks of life lost to COVID-19, the case of the United States.

Cuong Vu Manh

Abstract read
In one paragraph

Article in Immunity, inflammation and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Weeks of life lost to COVID-19, the case of the United States.Immunity, inflammation and disease · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Cuong Vu ManhInstitute of Research and Development, Duy Tan University, Da Nang, Viet Nam.ORCID 0000-0002-2426-2465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundYears of life lost (YLL) is a preferable indicator to assess the mortality impact of COVID-19. This indicator still has limits, however. Therefore, a new approach and its early-death weeks (eDW) index has been recently proposed to alter YLL. This study aims to add a new approach, the moving excess-deficit mortality model, and its method, the weeks of life lost (WLL) index. The new method was then used to measure WLL associated with COVID-19 in the United States (US).

methodsThe natural mortality law and the random pattern of spreading COVID-19 were employed to support calculating WLL. The natural mortality law implied that under the same living conditions and the weaker would die earlier. The random spreading of COVID-19 assumed that COVID-19 causes the weekly number of early deaths in equal proportions from all of those who would have died eventually distributed through the pandemic.

resultsFrom Week 02 of 2020 to Week 44 of 2021, we found that the US population has lost 56,270,300 weeks to COVID-19; the average WLL per COVID-19-related death is 74 or 1.4 in the unit of years.

conclusionsThe results do not depend on the high heterogeneity of deaths (e.g., age, gender, health status) and on whether COVID-19 is the main cause of death. The moving excess-deficit mortality model and WLL index can be applied promptly at any time and anywhere once excess deaths occurred during the pandemic. The index also provides critical insights into COVID-19, which can support making public health policies and decisions.

Indexed as

COVID-19HumansPandemicsUnited StatesCOVID-19deficit deathsmoving excess-deficit mortality modelweeks of life lost

Identifiers

PMID35759232
PMCPMC9208283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.